ProQR Therapeutics
Price & Volume
Stats
See more52W Range | $1.18-$4.62 |
Market Cap | $421.5M |
Shares Short | 677,628 |
Financials
See moreRevenue (12 Mos) | $15.7M |
Revenue Growth (YoY) | 419.8% |
Gross Profit (12 Mos) | $4.8M |
Diluted EPS | -$0.29 |
News
See moreYahoo Finance • last year
ProQR Announces Third Quarter 2023 Operating and Financial Results
Yahoo Finance • last year
ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing
Yahoo Finance • last year
ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference
Yahoo Finance • last year
ProQR Therapeutics Provides Update on Ophthalmic Assets
About
CEO | Mr. Daniel Anton de Boer |
Address | Zernikedreef 9, Leiden, Netherlands, 2333 CK |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 156 |
